Riskpilot← Back to searchSign inGet full accessØYELEGE LYSLO AS
ASActiveOrg 979846452Karisvingen 31, 9012 TromsøMedical specialists activities · NACE 8622Est. 19970 employees
Revenue 2024
NOK 131K
-58% vs 2023
EBITDA margin
11.9%
-91% vs 2023
Equity ratio
84.0%
Financial strength
Net profit 2024
NOK 813K
+141% vs 2023
| Revenue | NOK 131K | -58% |
| EBITDA | NOK 16K | -91% |
| Net profit | NOK 813K | +141% |
| Total assets | NOK 16M | +3% |
| Equity | NOK 13,5M | +3% |
| Employees | 0 | — |
Legal name
ØYELEGE LYSLO AS
Org number
979846452
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
31. desember 1997
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å drive øyelegeparksis, synskirurgi og alt som står i naturlig forbindelse med dette, herunder å delta i andre selskaper med lignende virksomhet, samt investeringsvirksomhet, herunder å kjøpe, selge, bytte og på annen måte forvalte aksjer, selskapsandeler, obligasjoner, verdipapirer, valuta og fondsandeler.
Address
Karisvingen 31, 9012 Tromsø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 453 | 2 049 | 714 | 314 | 131 |
| Staff expenses | −752 | −681 | −163 | −0 | −0 |
| EBITDA | 915 | 725 | 378 | 177 | 16 |
| Depreciation & amort. | −36 | −27 | −0 | −0 | −0 |
| EBIT | 879 | 698 | 378 | 177 | 16 |
| Net financials | 100 | 288 | 1 170 | 228 | 924 |
| Profit before tax | 979 | 986 | 1 549 | 405 | 939 |
| Tax | 200 | 155 | 181 | 69 | 126 |
| Net profit | 779 | 831 | 1 368 | 337 | 813 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 20 194 | 18 186 | 16 908 | 15 582 | 16 038 |
| Equity | 19 520 | 14 851 | 12 719 | 13 056 | 13 469 |
| Long-term debt | 60 | 44 | 145 | 116 | 93 |
| Short-term debt | 613 | 3 291 | 4 044 | 2 410 | 2 477 |
| Total debt | 674 | 3 335 | 4 189 | 2 526 | 2 569 |
EBITDA margin
11.9%
This company
15.8%
Market median
-25% vs market
20202024
Equity ratio
84.0%
This company
38.2%
Market median
+120% vs market
20202024
Return on equity
6.0%
This company
18.4%
Market median
-67% vs market
20202024
Net profit margin
619.1%
This company
8.1%
Market median
+7543% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS Deputy Member | Deputy Member | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2007 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ØYELEGE LYSLO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aleksandar Stojanovic | Deputy Member | 0 companies |
| Atle Lyslo | Chairman | 0 companies |